Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivian Arguello-Guerra

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ear, Nose, & Throat Journal|June 17, 2014
Sebaceous carcinoma of the parotid gland: a case report and review of the literatureAlexander Manteghi, Seth Zwillenberg, Vivian Arguello-Guerra
SAGE Open Medical Case Reports|January 27, 2018
Right orbital edema masquerading a hematologic malignancyAndrew C Tiu, Vivian Arguello-Guerra, Gabor Varadi
Case Reports in Hematology|November 6, 2019
Hemophagocytic Lymphohistiocytosis in an AIDS Patient with Kaposi Sarcoma: A Treatment DilemmaOluwadunni E Emiloju, Sorab Gupta, Vivian Arguello-Guerra, et al.
Archives of Pathology & Laboratory Medicine|March 17, 2022
CD30+ Lymphoproliferative Disorders as Potential Candidates for CD30-Targeted TherapiesRoland Schwarting, Eric Behling, Ashleigh Allen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ear, Nose, & Throat Journal|June 17, 2014
Sebaceous carcinoma of the parotid gland: a case report and review of the literatureAlexander Manteghi, Seth Zwillenberg, Vivian Arguello-Guerra
SAGE Open Medical Case Reports|January 27, 2018
Right orbital edema masquerading a hematologic malignancyAndrew C Tiu, Vivian Arguello-Guerra, Gabor Varadi
Case Reports in Hematology|November 6, 2019
Hemophagocytic Lymphohistiocytosis in an AIDS Patient with Kaposi Sarcoma: A Treatment DilemmaOluwadunni E Emiloju, Sorab Gupta, Vivian Arguello-Guerra, et al.
Archives of Pathology & Laboratory Medicine|March 17, 2022
CD30+ Lymphoproliferative Disorders as Potential Candidates for CD30-Targeted TherapiesRoland Schwarting, Eric Behling, Ashleigh Allen, et al.
Pageof 1